Protovo AI Vendor Invoice Auditor
Who Is the Company Behind Protovo AI Vendor Invoice Auditor?
- Seller: Protovo AI Vendor Invoice Auditor
- Year Founded: 2016
- HQ Location: Jaipur, IN
-
LinkedIn® Page: www.linkedin.com
8 employees on LinkedIn®
Total Products under this Category: 1,247
Last updated: November 01, 2026
Why You Can Trust G2's Software Rankings:
G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.

Highlighted products: Gemini platform, SAS Viya, IBM watsonx.ai, Azure OpenAI Service, Google Cloud Recommendations AI, Alteryx, Amazon Personalize, and Google Cloud TPU.
Underlying data: [Grid® JSON](https://www.g2.com/categories/machine-learning/grids.json?focus%5B%5D=gemini-platform&focus%5B%5D=sas-sas-viya&focus%5B%5D=ibm-watsonx-ai&focus%5B%5D=azure-openai-service&focus%5B%5D=google-cloud-recommendations-ai&focus%5B%5D=alteryx&focus%5B%5D=amazon-personalize&focus%5B%5D=google-cloud-tpu)
Proxima is a pioneering biotechnology company dedicated to revolutionizing medicine by making protein interactions programmable. By integrating advanced artificial intelligence with structural biology, Proxima aims to unlock new therapeutic possibilities through precise modulation of protein functions. Key Features and Functionality: - Neo-1 Model: Proxima's foundational AI model, Neo-1, unifies structure prediction and molecular design at an atomic level. It enables the design of biomolecules and accelerates structural data collection when combined with the NeoLink platform. - NeoLink Platform: This innovative structural data generation platform utilizes cross-linking mass spectrometry (XLMS) to measure interatomic distances at scale, providing high-throughput snapshots of structural interactions. - Integrated Discovery Platform: Proxima combines three complementary, phase-shifting technologies to fully exploit the potential of proximity modulator modalities, facilitating the development of novel therapeutics. Primary Value and Solutions: Proxima addresses the challenge of targeting intracellular proteins, which are often inaccessible to traditional therapies. By reprogramming existing cellular proteins and directing them toward new targets using small molecules, peptides, or macrocycles, Proxima enables the treatment of diseases previously considered untreatable. This approach opens a new chapter in medicine, offering hope for patients with limited treatment options.
Connect G2 to Claude or ChatGPT for answers grounded in G2's trusted reviews, comparisons, and pricing from real user insights.
Puls8™ RGOX is an AI-driven Revenue Growth Optimization solution designed to transform how consumer goods companies plan, optimize, and execute trade promotions. By integrating AI-powered forecasting, optimization, and scenario planning directly into the planning workflow, Puls8™ RGOX replaces traditional manual processes with intelligent automation, enabling faster and more effective decision-making. Key Features and Functionality: - AI-Driven Promotional Forecasting: Utilizes advanced AI models to provide accurate lift forecasts, enhancing alignment and accuracy in demand planning systems. - Automated Scenario Planning: Allows rapid creation, comparison, and combination of multiple promotional strategies before committing resources, facilitating informed decision-making. - Incremental Trade Dollar Optimization: Enables teams to improve return on investment by optimizing around existing or approved promotional plans, ensuring efficient use of trade funds. - Flexible Constraint Management: Offers comprehensive management of global and local constraints, including pinned promotions, blocked time periods, and calendar-aware optimization, providing adaptability to various planning requirements. - Seamless Downstream Integration: Ensures optimized promotional plans flow directly into Trade Promotion Management (TPM), Enterprise Resource Planning (ERP), and forecasting systems, eliminating manual data entry and reducing reconciliation efforts. Primary Value and Problem Solved: Puls8™ RGOX addresses the inefficiencies of traditional trade promotion planning, which often rely on slow, manual processes leading to misaligned forecasts and underperforming promotions. By automating and optimizing these processes with AI, Puls8™ RGOX empowers organizations to plan faster, forecast more accurately, and focus on strategic initiatives rather than data entry. This results in improved trade return on investment, enhanced forecast accuracy, and more agile operations, ultimately driving sustainable revenue growth.
Pulsarion Network is an innovative trading platform that leverages advanced artificial intelligence (AI) technologies to streamline trading processes and maximize profits for both novice and experienced traders. By automating routine tasks and providing real-time market analysis, it empowers users to make informed investment decisions efficiently. Key Features and Functionality: - AI-Driven Market Analysis: Utilizes sophisticated AI algorithms to analyze financial markets, delivering accurate trading signals and insights. - Automated Trading: Offers automation capabilities that execute trades based on predefined parameters, reducing manual intervention and enhancing efficiency. - Multi-Asset Support: Supports a diverse range of assets, including cryptocurrencies, forex, stocks, and commodities, allowing users to diversify their portfolios. - User-Friendly Interface: Features an intuitive interface designed to accommodate traders of all experience levels, facilitating easy navigation and operation. - Educational Resources: Provides comprehensive educational materials to assist users in understanding market dynamics and refining their trading strategies. Primary Value and User Solutions: Pulsarion Network addresses common challenges in the trading landscape by simplifying complex market analyses and automating trading activities. This approach minimizes the time and effort required for market monitoring and decision-making, thereby reducing the risk of human error. The platform's AI-driven insights and automation tools enable users to capitalize on market opportunities promptly, enhancing their potential for profit. Additionally, its support for multiple asset classes allows traders to diversify their investments, mitigating risk and optimizing returns.
room quantum computing to quantum sensing in defense, Q-CTRL deploys our world-leading expertise in quantum control engineering as intuitive software to help make quantum technology useful. Our unique software helps solve today’s biggest challenges for quantum technology in the NISQ era and beyond; noise and decoherence. Quickly build intuition for the impact of noise and errors in quantum computers with Q-CTRL, and deploy our expert solutions to stabilize real hardware.
QFlow delivers advanced BizOps capabilities out of the box: multi-quarter scenario forecasting, GTM stats for revenue waterfalls, and ML-driven analysis of performance drivers with views that are impossible in Salesforce, marketing automation systems, and data warehouses. All without the need for additional analysts, engineers, or ML experts. All via an interface easily understood by busy CxOs, including bullet points and generative text.
Average Rating: 4.8/5.0
Total Reviews: 5
"Incredible data and purpose built for RevOps and finance teams"
Rating: 5.0/5.0 stars
— Anthony E.
"MY one stop shop for understanding our data"
Rating: 5.0/5.0 stars
— Cliff S.
Qubole is the open data lake company that provides a simple and secure data lake platform for machine learning, streaming, and ad-hoc analytics. No other platform provides the openness and data workload flexibility of Qubole while radically accelerating data lake adoption, reducing time to value, and lowering cloud data lake costs by 50 percent. Qubole’s Platform provides end-to-end data lake services such as cloud infrastructure management, data management, continuous data engineering, analytics, and machine learning with near-zero administration. Qubole is trusted by leading brands such as Expedia, Disney, Oracle, Gannett and Adobe to spur innovation and to transform their businesses for the era of big data. For more information, visit us at www.qubole.com.
Average Rating: 4.0/5.0
Total Reviews: 237
"Qubole is an amazing data lake platform for analytics"
Rating: 5.0/5.0 stars
— Parth C.
"Great and easy to implement tool to manage big data"
Rating: 5.0/5.0 stars
— Muhammad D.
Quris-AI is a pioneering biotechnology company that leverages artificial intelligence and advanced genomic technologies to revolutionize drug development. By integrating AI-driven predictive models with patient-derived tissue samples, Quris-AI aims to enhance the accuracy and efficiency of preclinical drug testing, reducing the reliance on animal models and increasing the likelihood of clinical success. Key Features and Functionality: - AI-Powered Drug Testing: Utilizes machine learning algorithms to predict drug efficacy and safety, streamlining the preclinical testing phase. - Patient-on-a-Chip Technology: Employs microfluidic devices that mimic human organ systems, allowing for more accurate simulation of human responses to drugs. - Data-Driven Insights: Analyzes vast datasets to identify potential drug candidates and optimize therapeutic strategies. - Reduced Animal Testing: Offers an ethical and more predictive alternative to traditional animal testing methods. Primary Value and User Solutions: Quris-AI addresses the high failure rates and ethical concerns associated with conventional drug development processes. By providing a more accurate and humane testing platform, it enables pharmaceutical companies to identify promising drug candidates earlier, reduce development costs, and accelerate the time-to-market for new therapies. This approach not only enhances patient safety but also increases the overall efficiency and success rates of drug development pipelines.